Skip to main content
CLGN
NASDAQ Industrial Applications And Services

Loewenbaum Family Group Lifts CollPlant Stake to 33% Following Warrant Exercise

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.273
Mkt Cap
$5.158M
52W Low
$0.27
52W High
$3.232
52W Position info
1.1% above low
Off High info
92% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CLGN is trading near its 52-week low of $0.27 (1.1% above the low).

Summary

The Loewenbaum family group has raised its CollPlant stake to 33.0% from 18.6% after exercising warrants, enabled by shareholder approval to increase authorized shares.


Key Events · Ownership and Investor Activity · CLGN

  • Stake Increased to 33.0%

    Beneficial ownership now stands at 7,473,536 ordinary shares, or 33.0% of the outstanding shares, up from 18.6% previously, following the exercise of warrants acquired in the June 2026 private placement.

  • Warrant Exercise Enabled by Shareholder Vote

    The exercise was made possible by shareholder approval on July 29, 2026, to increase authorized shares, allowing the Loewenbaum 1992 Trust to exercise Series A and B warrants at $0.34 per share—above the current stock price of $0.27.

  • Concentrated Ownership Amid Financial Distress

    With a 33.0% stake, the group gains significant influence at a time when CollPlant is grappling with a severe revenue decline (Q1 2026 revenue of $73,000) and a stock price hovering near its 52-week low of $0.27.

  • Prior Disclosure Updated

    This amendment updates the July 27, 2026 Schedule 13D/A, which had reported an 18.6% stake, to reflect the warrant exercise and the resulting increase in beneficial ownership.


Analysis · CLGN · Industrial Applications And Services

Already a major investor, the Loewenbaum family group has raised its beneficial ownership in CollPlant from 18.6% to 33.0% by exercising warrants obtained in the recent $2.6 million private placement. The move comes after shareholders approved an increase in authorized shares on July 29, 2026, clearing the way for the warrant exercise. With control of a third of the company, the group now holds a concentrated position that could shape corporate decisions—a notable development given CollPlant's severe financial distress, collapsing revenues, and a stock price near all-time lows. While the increased stake underscores the family's commitment, it also raises governance considerations in light of the company's precarious state.

At the time of this filing, CLGN was trading at $0.27 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.2M. The 52-week trading range was $0.27 to $3.23. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CLGN - Latest Insights

CLGN
Jul 28, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.3278
Real-time Price: $0.2728 info
Change: -$0.055 (-17%) info
Market Cap: $5.158M info
CLGN
Jul 27, 2026, 4:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.305
Real-time Price: $0.2728 info
Change: -$0.0322 (-11%) info
Market Cap: $5.158M info
CLGN
Jul 09, 2026, 4:25 PM EDT
Filing Type: F-3
Importance Score:
8
Price at Filing: $0.3587
Real-time Price: $0.2728 info
Change: -$0.0859 (-24%) info
Market Cap: $5.158M info
CLGN
Jul 07, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.360
Real-time Price: $0.2728 info
Change: -$0.0872 (-24%) info
Market Cap: $5.158M info
CLGN
Jul 01, 2026, 8:36 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.343
Real-time Price: $0.2728 info
Change: -$0.0702 (-20%) info
Market Cap: $5.158M info